ArticleBlood advances2023

Real-world comparative effectiveness of acalabrutinib and ibrutinib in patients with chronic lymphocytic leukemia.

Lindsey E Roeker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.